Webinar: CER Collaborative: Tools You Can Use

Collaborative members hosted a webinar explaining how to use the tools they developed to create greater uniformity and transparency when evaluating evidence for coverage and health care decision-making. Leading researchers taught attendees about how these tools can help to ensure research studies are credible and relevant for decision-makers.

Topics included:

• Compilations of good outcomes research practices for individual studies (e.g., prospective and retrospective observational studies, modeling approaches, indirect treatment comparisons);
• Academy of Managed Care Pharmacy’s perspective on how the CER Collaborative’s resources can benefit formulary decision-makers;
• New Comparative Effectiveness Research Continuing Education Certificate Program; and
• NPC’s perspective on how the tools can assist the pharmaceutical industry.

Speakers:

• Brian Sweet, Executive Director, U.S. Payer & Real World Evidence, AstraZeneca (moderator)
• Marc Berger, Vice President, Real World Data And Analytics, Pfizer
• Dan Allen, clinical pharmacist consultant, OmedaRx 
• Bernadette Eichelberger, Director, Pharmacy Affairs, AMCP
• Jennifer Graff, director, comparative effectiveness research, NPC